Revascor trials dawdling, page-3

First 3 Last

Share
Profile

Follow
antibody

3,535 Posts.

3340

18/07/14

14:34

Post #: 13680756
Share

Originally posted by jeroenn1 ↑

I have had a theory for a while now that MSB/Teva are planning for the whole platform with a number of products to be going into commercial approval in 2018.

The initial piece of the puzzle was the deliberate delay with the bone marrow phase three trial. It is impossible to believe that any trial can take over 7 hears to complete without a rational explanation.

We shareholders are left to speculate why ?

My rationale is that MSB's patent library may probably allow for patent extensions. The early commercialisation of one product that uses a suite of patents across a platform will subtract from MSB's ability to negotiate patent extensions.

I also believe the "Japanese Commercialisation Strategy" is due for an announcement as predicted in presentations in the first quarter. Unfortunately for some shareholders it may not be what they want to hear due to the probable patent extension strategy.

Yes my thoughts are pure speculation as no amount of research can uncover the mysteries surrounding MSB.

I am however holding from the point of view that the multiple product launch in 2018 will commercially be the biggest and most exciting medical event in history.

As a small bonus we will likely enjoy the early commercialisation of the Osiris products.

Expand

The various ideas speculated in this post would most certainly be very welcome to the unidentified big traders on the BUY side of Mesoblast.

MSB Price at posting: $4.12 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SER

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

ASX Market Open: Can we squeeze one more record reset into Week 29? | July 18

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

AII

A new NASDAQ listing for a key player in the global critical minerals space

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.33		Change 0.540(30.2%)		Mkt cap ! $2.995B

Open	High	Low	Value	Volume
$1.90	$2.40	$1.90	$31.78M	14.50M

Buyers (Bids)

No.	Vol.	Price($)
26	44972	$2.32

Sellers (Offers)

Price($)	Vol.	No.
$2.33	67497	7

View Market Depth

No.	Vol.	Price($)
14	23570	2.290
18	61067	2.280
19	67421	2.270
14	103036	2.260
11	34892	2.250

Price($)	Vol.	No.
2.300	28254	15
2.310	227214	27
2.320	58217	12
2.330	299068	9
2.340	28797	7

Last trade - 12.15pm 18/07/2025 (20 minute delay)

MSB (ASX) Chart

Revascor trials dawdling, page-3

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

ASX Market Open: Can we squeeze one more record reset into Week 29? | July 18

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

A new NASDAQ listing for a key player in the global critical minerals space

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Revascor trials dawdling, page-3

Top Stories

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

ASX Market Open: Can we squeeze one more record reset into Week 29? | July 18

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

A new NASDAQ listing for a key player in the global critical minerals space

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News